News & Updates
Inside Innovation
The latest news and advances from the world's most exciting life science cluster.

Merck, Seattle Genetics form partnerships worth $4.5B focused on two cancer drugs
Pharmaceutical company Merck and Bothell, Washington-based Seattle Genetics have formed a partnership to advance two key cancer therapies. The first involves expanding Tukysa, the drug

Gilead Moves Deeper into Oncology with $21 Billion Acquisition of Immunomedics
Gilead Sciences announced it has acquired Immunomedics, a developer of antibody-drug conjugate (ADC) technology used to treat cancers. Immunomedics gained attention with the success of

Seattle Genetics plans manufacturing expansion with cash from Merck deal
Following a blockbuster deal with pharmaceutical company Merck, Seattle Genetics released plans to build a $300 million manufacturing facility, two to three times the size

Study: Washington ranked best state to work in during COVID-19 pandemic
Washington was named the best state to work in during the COVID-19 pandemic, according to a report released by Oxfam America. The study looked at

Seattle biotech startup led by Fred Hutch, Adaptive vets raises $16M for rapid drug development tech
Investment into the Seattle biotech scene continues as Lumen Bioscience announced it received $16 million in Series B funding. The startup, led by former Adaptive

Seattle’s Athira Pharma files for IPO to fund quest for Alzheimer’s and Parkinson’s breakthroughs
Athira Pharma, which develops therapies for brain diseases such as Alzheimer’s and Parkinson’s, filed for an IPO last week. Athira’s regenerative technology works to rebuild

Eyedropper startup Nanodropper lands new $500k Air Force contract as it begins shipping device
Nanodropper, a medical device startup launched by a group of University of Washington students, announced that it received $500,000 in funding from the United States

State life science industry launches job push
Amid an economic downturn, Washington state’s life science industry is growing and hiring for hundreds of open positions at all levels. To fuel this expansion,

Bristol Myers Squibb Pledges $300 Million To Address Racial Inequality In Healthcare
Bristol Myers Squibb announced that it will commit $300 million over the next five years to tackle racial health disparities and accelerate its diversity and

Life Science Industry in Washington Continuing to Grow and Hire Amid COVID-19
Life Science Washington announced the launch of its new campaign, “Find Your Best Life in Washington,” to encourage top talent nationwide to learn more about

Chinook Therapeutics brings in $106M ahead of reverse merger
Chinook Therapeutics, a Vancouver, B.C. based company with offices in Seattle, raised $106 million in advance of an upcoming reverse merger with Berkeley, California-based Aduro

Meet the 21 biotech startups that top VCs say are poised to take off in the next 12 months
Seattle-based Sana Biotechnology and Silverback Therapeutics are among the 21 biotech startups that 12 top biotech venture capital investors are eyeing for investment opportunities in
